TRELEGY ELLIPTA (fluticasone
furoate, umeclidinium, and vilanterol inhalation powder) MOBILE PROGRAM
TERMS
1. By opting in to the
TRELEGY (fluticasone furoate, umeclidinium, and vilanterol inhalation powder) Text Message Program (the
“Program”), in which you consent to receive approximately 10 text messages and/or push
notifications per month from EngagedMedia using autodialer technology (including text messages). Consent is
not a condition of purchase. Such messages may be marketing or non-marketing messages and may include, for
example, refill reminders, fill confirmation, website information, etc. Carriers are NOT liable for delayed
or undelivered messages.
2. To stop receiving text
messages, text STOP to 267-89 or the short code from which you received a message. DOING SO WILL ONLY OPT
YOU OUT OF THE TRELEGY (fluticasone furoate, umeclidinium, and vilanterol inhalation powder) MOBILE PROGRAM;
you will remain opted in to any other GSK text message program(s) to which you separately opted in. If
enrolled in push notifications, you may unsubscribe at any time by going into the digital wallet on your
device and disabling push notifications in the digital wallet Program pass or by removing the digital wallet
Program pass from your device.
3. To request more
information or to obtain help, text HELP to 267-89 or the short code from which you received a message. You
can also call customer service at 1-888-825-5249.
4. By opting in to the
Program, you also agree to sharing your phone number with EngagedMedia for the purpose of enrolling you into
the text program.
5. You represent that you
are the account holder for the mobile telephone number(s) that you provide to opt in to the texting program.
You are responsible for notifying GSK immediately if you change your mobile telephone number. You may notify
GSK of a number change by re-enrolling in the program.
6. Message and data rates
may apply to each text message sent or received in connection with the texting program, as provided in your
mobile telephone service rate plan, in addition to any applicable roaming charges. Charges are both billed
and payable to your mobile service provider or deducted from your prepaid account. GSK does not impose a
separate fee for sending text messages.
7. Data obtained from you
in connection with the Program may include your telephone number; your carrier's name; and the date,
time, content of your messages, and device information. This data may be used to administer the Program.
Please read our full Privacy Policy, which is incorporated by reference into these Terms and
Conditions.
8. In addition to the
data use practices described in the Privacy Policy, GSK may send you offer-related push notifications when
your device is in the physical proximity of your pharmacy or healthcare provider. This is done through
geofencing technology, which is built in to your device. Your device’s location will not be known or
tracked by GSK or its service providers. Nonetheless, you may opt out of geofencing and receiving these
notifications at any time by (1) disabling location services for your digital wallet app in your
device’s settings, (2) disabling notifications (i.e., automatic updates) within the digital wallet
app, or (3) removing the eCard from your digital wallet by selecting “Remove Pass” within the
digital wallet app.
9. Neither GSK nor
EngagedMedia will be liable for any delays in the receipt of any SMS messages, as delivery is subject to
effective transmission from your network operator.
10. This service is
available only on US participating mobile carriers.
11. You agree to
indemnify GSK and EngagedMedia in full for all claims, expenses, and damages related to or caused in whole
or in part by your failure to notify us if you change your telephone number, including but not limited to
all claims, expenses, and damages related to or arising under the Telephone Consumer Protection
Act.
12. NO CLASS ACTIONS: you
may only bring individual claims. Under no circumstance are you allowed to bring a claim as a punitive or
named plaintiff or a class member in a class. Class action lawsuits, class-wide arbitrations, private
attorney-general actions, and any other proceedings where someone acts in a representative capacity are not
allowed. Any combining of individual proceedings must have the consent of all
parties.
13. GSK may suspend or
terminate your receipt of text messages if it believes you are in breach of these Terms and Conditions. Your
receipt of text messages is also subject to termination in the event that your mobile telephone service
terminates or lapses. GSK reserves the right to modify or discontinue, temporarily or permanently, all or
any part of the text messaging services you receive, with or without notice.
14. GSK may revise,
modify, or amend these Terms and Conditions at any time. Any such revision, modification, or amendment shall
take effect when it is posted to GSK’s website. You agree to review these Terms and Conditions
periodically to ensure that you are aware of any changes. Your continued consent to receive text messages
will indicate your acceptance of those changes.
SAVINGS OFFER TERMS AND
CONDITIONS
ELIGIBILITY: Patients may be eligible
for this offer if they have commercial insurance and insurance does not cover the full cost of the
prescription, or if they are not insured and are responsible for the cost of their prescriptions. Patients
are not
eligible for this program if they are covered by any federal or state prescription insurance program. This
includes
patients enrolled in Medicare Part B, Medicare Part D, Medicaid, Medigap, Veterans Affairs (VA), Department
of
Defense (DoD) programs, or TRICARE. This may also include state pharmaceutical assistance programs and other
federal
or state plans not listed. Patients are also ineligible for this program if they are Medicare eligible and
enrolled in an employer-sponsored group waiver health plan or government-subsidized prescription drug
benefit program
for retirees. Patients enrolled in a state or federally funded prescription insurance program may not use
this
program even if they elect to be processed as an uninsured (cash-paying) patient. Those on Medicare Part D,
even if
in the coverage gap, are not eligible. Patients enrolled in private indemnity or HMO insurance plans that
reimburse
them for the entire cost of their prescription drugs are also not eligible. This offer is not health
insurance and is restricted to residents of the United States, Puerto Rico, and US territories.
Void where prohibited by law, taxed, or restricted.
TERMS OF
USE:
Eligible
commercially insured/covered patients with no restrictions (step-edit, prior authorization, or NDC block)
and
with a valid prescription for TRELEGY (fluticasone furoate, umeclidinium, and vilanterol inhalation powder)
who
present this savings card at participating pharmacies will pay as little as $0 for each covered 30-, 60-, or
90-
day supply (1-3 inhalers) of TRELEGY. Maximum savings from offer will not exceed $500 per month between
January
1, 2024 and March 31, 2024; and $200 per month at all other times for patient’s out-of-pocket cost
(the
amount paid after insurance deductions, if any). If you pay cash for your prescription, or are insured and
your
insurance does not cover or has a managed care restriction (step-edit, prior authorization, or NDC block),
and
are not a government beneficiary or Medicare eligible, you will receive up to $100 in savings on your
out-of-pocket costs for each 30-day supply. This offer is valid for up to 12 uses, and each 30-day supply
counts
as 1 use. Other restrictions may apply. Patient is responsible for applicable taxes, if any. This offer is
limited to 1 per person and is nontransferable and cannot be combined with any other coupon, free trial, or
similar offer. No substitutions are permitted. Patients, pharmacists, and prescribers cannot seek
reimbursement
from health insurance or any third party for any part of the amount received by the patient through this
offer.
Offer must be presented along with a valid prescription for TRELEGY at the time of purchase. Your acceptance
of
this offer must be consistent with the terms of any drug benefit plan provided to you by your health
insurer.
You agree to report your use of this coupon to your health insurer if required.
GSK or McKesson (on
GSK’s
behalf) reserves the right to rescind, revoke, or amend this offer at any time without notice. This offer
may
not be sold, purchased, traded, or counterfeited. Duplicates of this uniquely coded offer are invalid
and not redeemable at the pharmacy. This offer is not conditioned on any past, present, or future purchase,
including refills. This offer expires on 12/31/2024.